BillionToOne Partners With Epic To Integrate BillionToOne's Prenatal And Oncology Testing Portfolio With Epic's Aura Diagnostics Suite

BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced a collaboration with Epic, the nation's most widely used comprehensive electronic health record (EHR). The agreement, signed in December 2025, will integrate BillionToOne's prenatal and oncology testing portfolio with Epic's Aura diagnostics suite.

Through the integration, clinicians will be able to order BillionToOne's UNITY Complete® prenatal test as well as Northstar Select® and Northstar Response® liquid biopsy tests directly within Epic. Discrete test results then flow back into the electronic health record, where they can power downstream clinical decision support and a simpler experience for patients and providers in health systems, community practices, maternal-fetal medicine practices, and oncology clinics.